The FDA has warned about potential risks, including serious side effects, from unapproved compounded versions, especially when they use different forms of the active ingredient (like "semaglutide sodium" or "tirzepatide acetate") than the approved drugs
The count of reviews lands at 19 with a 4.0/5 rating
Understand the COA matters more here than usual
Hunan University of Chinese Medicine Postgraduate Innovation Project (2024CX152, 2024CX151, 2024CX150)
Talk with a licensed provider at Independent Wellness to review your options and build a plan designed for safe, sustainable results
While researchers are still working out exactly how, GLP-1 drugs seem to be "ratcheting down reward center drivers," Dr